Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 202

    1.

    Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.

    O'Hara GA, Duncan CJ, Ewer KJ, Collins KA, Elias SC, Halstead FD, Goodman AL, Edwards NJ, Reyes-Sandoval A, Bird P, Rowland R, Sheehy SH, Poulton ID, Hutchings C, Todryk S, Andrews L, Folgori A, Berrie E, Moyle S, Nicosia A, Colloca S, Cortese R, Siani L, Lawrie AM, Gilbert SC, Hill AV.

    J Infect Dis. 2012 Mar;205(5):772-81. Epub 2012 Jan 24.

    PMID:
    22275401
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.

    El Sahly HM, Davis C, Kotloff K, Meier J, Winokur PL, Wald A, Johnston C, George SL, Brady RC, Lehmann C, Stokes-Riner A, Keitel WA.

    J Infect Dis. 2012 Mar;205(5):703-12. Epub 2012 Jan 24.

    PMID:
    22275399
    [PubMed - indexed for MEDLINE]
    3.

    More lessons from the Taiwanese hepatitis B virus vaccine program.

    Schwarz KB.

    J Infect Dis. 2012 Mar;205(5):702. Epub 2012 Jan 19. No abstract available.

    PMID:
    22262789
    [PubMed - indexed for MEDLINE]
    4.

    Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.

    Khurana S, Verma N, Talaat KR, Karron RA, Golding H.

    J Infect Dis. 2012 Feb;205(4):610-20. Epub 2011 Dec 29.

    PMID:
    22207649
    [PubMed - indexed for MEDLINE]
    5.

    Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial.

    Liao G, Li R, Li C, Sun M, Li Y, Chu J, Jiang S, Li Q.

    J Infect Dis. 2012 Jan 15;205(2):237-43. Epub 2011 Dec 8.

    PMID:
    22158682
    [PubMed - indexed for MEDLINE]
    6.

    The final phase of polio eradication: new vaccines and complex choices.

    Cochi SL, Linkins RW.

    J Infect Dis. 2012 Jan 15;205(2):169-71. Epub 2011 Dec 8. No abstract available.

    PMID:
    22158681
    [PubMed - indexed for MEDLINE]
    7.

    Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa.

    Waggie Z, Geldenhuys H, Sutter RW, Jacks M, Mulenga H, Mahomed H, De Kock M, Hanekom W, Pallansch MA, Kahn AL, Burton AH, Sreevatsava M, Hussey G.

    J Infect Dis. 2012 Jan 15;205(2):228-36. Epub 2011 Dec 8.

    PMID:
    22158680
    [PubMed - indexed for MEDLINE]
    8.

    Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.

    Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, Baumbach J, Beall B, Jorgensen J, Glennen A, Zell ER, Moore M.

    J Infect Dis. 2012 Feb;205(3):401-11. Epub 2011 Dec 7.

    PMID:
    22158567
    [PubMed - indexed for MEDLINE]
    9.

    Diet-induced obesity dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse model.

    Kim YH, Kim JK, Kim DJ, Nam JH, Shim SM, Choi YK, Lee CH, Poo H.

    J Infect Dis. 2012 Jan 15;205(2):244-51. Epub 2011 Dec 5. Erratum in: J Infect Dis. 2012 Apr;205(8):1330.

    PMID:
    22147801
    [PubMed - indexed for MEDLINE]
    10.

    Influenza and obesity: will vaccines and antivirals protect?

    Beck MA.

    J Infect Dis. 2012 Jan 15;205(2):172-3. Epub 2011 Dec 5. No abstract available.

    PMID:
    22147797
    [PubMed - indexed for MEDLINE]
    11.

    GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.

    Behzad H, Huckriede AL, Haynes L, Gentleman B, Coyle K, Wilschut JC, Kollmann TR, Reed SG, McElhaney JE.

    J Infect Dis. 2012 Feb;205(3):466-73. Epub 2011 Dec 5.

    PMID:
    22147791
    [PubMed - indexed for MEDLINE]
    12.

    Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities.

    Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R, Perilla MJ, Jackson DM, Beall B, Craig MJ, Reid R, Santosham M, O'Brien KL.

    J Infect Dis. 2012 Jan 15;205(2):280-8. Epub 2011 Nov 29.

    PMID:
    22128315
    [PubMed - indexed for MEDLINE]
    13.

    Small-particle aerosolization of live attenuated influenza vaccine virus.

    Ambrose CS, Coelingh KL.

    J Infect Dis. 2012 Jan 15;205(2):348; author reply 348-9. Epub 2011 Nov 28. No abstract available.

    PMID:
    22124134
    [PubMed - indexed for MEDLINE]
    14.

    Error occurred: cannot get document summary

    PMID:
    22124132

    15.

    Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.

    Siddiqui F, O'Connor JR, Nagaro K, Cheknis A, Sambol SP, Vedantam G, Gerding DN, Johnson S.

    J Infect Dis. 2012 Jan;205(1):128-33. Epub 2011 Nov 28.

    PMID:
    22124129
    [PubMed - indexed for MEDLINE]
    16.

    A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies.

    Fritz R, Sabarth N, Kiermayr S, Hohenadl C, Howard MK, Ilk R, Kistner O, Ehrlich HJ, Barrett PN, Kreil TR.

    J Infect Dis. 2012 Jan;205(1):28-34. Epub 2011 Nov 16.

    PMID:
    22090447
    [PubMed - indexed for MEDLINE]
    17.

    Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses.

    Desel C, Dorhoi A, Bandermann S, Grode L, Eisele B, Kaufmann SH.

    J Infect Dis. 2011 Nov 15;204(10):1573-84. Epub 2011 Sep 20.

    PMID:
    21933877
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection.

    Tsuda Y, Safronetz D, Brown K, LaCasse R, Marzi A, Ebihara H, Feldmann H.

    J Infect Dis. 2011 Nov;204 Suppl 3:S1090-7.

    PMID:
    21987746
    [PubMed - indexed for MEDLINE]
    19.

    Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.

    Falzarano D, Feldmann F, Grolla A, Leung A, Ebihara H, Strong JE, Marzi A, Takada A, Jones S, Gren J, Geisbert J, Jones SM, Geisbert TW, Feldmann H.

    J Infect Dis. 2011 Nov;204 Suppl 3:S1082-9.

    PMID:
    21987745
    [PubMed - indexed for MEDLINE]
    20.

    Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.

    Geisbert TW, Feldmann H.

    J Infect Dis. 2011 Nov;204 Suppl 3:S1075-81. Review.

    PMID:
    21987744
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk